Other Information.
−Removed: Not applicable .
3.1 Ninth Amended and Restated Certificate of Incorporation (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K, filed on March 28, 2014).
2 unchanged sentences
(incorporated by reference to Exhibit 3.1 to the Company's Current Report on Form 8-K, filed on June 9, 2020).
−Removed: 10.1*† Consulting Agreement by and between the Company and Jason A.
−Removed: Amello, dated August 7, 2020.
−Removed: 10.2# Amended and Restated Product Manufacture and Supply and Facility Construction Agreement between BioVectra, Inc.
−Removed: and Keryx Biopharmaceuticals, Inc., dated September 4, 2020 (incorporated by reference to Ex hibit 10.1 to the Company's Current Report on Form 8-K, filed on September 11, 2020) .
+Added: 10.1† Non-Employee Director Compensation Program, effective January 26, 2021 (incorporated by reference to Exhibit 10.19 to the Company 's Ann ual Report on Form 10-K , filed on February 25, 2021 ) .
+Added: 10.2 Amendment No.
+Added: 2 to Master Manufacturing Services and Supply Agreement, dated as of January 29, 2021, by and between Siegfried Evionnaz SA and Keryx Biopharmaceuticals, Inc.
+Added: (incorporated by reference to Exhibit 10.
+Added: 58 to the Company's Annual Report on Form 10-K, filed on February 25, 2021) .
+Added: 10.3# Amendment No.
+Added: 3 to Master Manufacturing Services and Supply Agreement, dated as of February 11, 2021, by and between Siegfried Evionnaz SA and Keryx Biopharmaceuticals, Inc.
+Added: (incorporated by reference to Exhibit 10.
+Added: 5 9 to the Company's Annual Report on Form 10-K, filed on February 25, 2021)
+Added: 10.4*# Supply Agreement, dated February 10, 2021, by and between the Company and STA Pharmaceutical Hong Kong Limited.
+Added: 10.5*# Royalty Interest Acquisition Agreement, dated February 25, 2021, by and between the Company and HealthCare Royalty Partners IV, L.P.
31.1* Certification of Principal Executive Officer Required Under Rule 13a-14(a) of the Securities Exchange Act of 1934, as amended.
13 unchanged sentences
AKEBIA THERAPEUTICS, INC.
−Removed: November 5, 2020 By:
−Removed: President and Chief Executive Officer
−Removed: November 5, 2020 By:
−Removed: Senior Vice President, Chief Financial Officer and Treasurer
+Added: May 10, 2021 By:
+Added: President and Chief Executive Officer (Principal Executive Officer)
+Added: May 10, 2021 By:
+Added: Senior Vice President, Chief Financial Officer and Treasurer (Principal Financial Officer)
+Added: May 10, 2021 By:
+Added: /s/ Violetta Cotreau
+Added: Violetta Cotreau
+Added: Senior Vice President, Chief Accounting Officer (Principal Accounting Officer)
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.